<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">
Webinar download header

Missed our live webinar? Download the full recording now!

About this Webinar

With more than 80% of US clinical trials failing to meet their patient enrollment timelines and with an average of 30% of patients dropping out, clinical research professionals are always searching for ways to avoid these common issues.

In this interactive discussion, learn from four experts representing different roles in launching new studies on common issues and solutions they see from the most pivotal part; the protocol.


Hear from our expert panel on how to:

  • - Get strategic partners involved in protocol design 
  • - Reduce wasted time and efforts with protocol design and amendments
  • - Optimize the SOA for the patient experience
  • - Get ahead of recruitment and enrollment issues
  • - Reduce the barriers to participation 
  • - Incorporate hybrid or decentralized strategies within your trial design
  •  

Meet Our Panelists

rehan

Rehan Ahmed MD

Ophthalmologist & Global Director Development and Operations Santen

Rehan Ahmed is a Medical Director in Global Clinical Development and Operations at Santen Pharmaceutical, where he is responsible for designing and executing studies through the range of clinical development. He is a board-certified ophthalmologist, founder of Texas Eye and Vision Associates, and a partner at the Memorial Hermann Southwest Surgical Center. 

 
jill-Headhot

Jill Healy

CEO
Trial Runners

Jill Healy provides leadership over business and clinical operations at Trial Runners. Since its launch in 2006, Jill has provided direction to clinical teams on over fifty clinical trials. Prior to Trial Runners, Jill was with Eyetech Pharmaceuticals, most recently as Associate Director in the Clinical Department where she hired, trained and mentored CRA staff members working on Macugen® clinical trials.

jess

Jess Mays

Vice President, Life Sciences
20/20 Onsite

Jess Mays is Vice President of Life Sciences at 20/20 Onsite. She prides herself on honesty and authenticity, bringing humanity (and a smile) to everything she does. Jess is an experienced early-stage company development professional with a focus on customer engagement, operations, and new business development.

lisa

Lisa Williams

Director, Clinical Trials Services
Vestrum Health, Division of CorEvitas

Lisa Williams worked the early parts of her career in a busy retina practice as a scribe, photographer, certified visual acuity examiner, and later, as a study coordinator across many trials.

Lisa joined the Vestrum team in 2021 and has greatly enjoyed watching the Vestrum Clinical Trials team grow and is very excited for what the future holds.

bren

Moderated by Bernadette Tosti, an Independent Consultant and Advisor

Bernadette Tosti is the founder of BGT Partners and was previously Vice President, Patient Experience at Science 37 where she led all patient access and engagement activities including feasibility, provider network, and patient outreach.  Prior to her role at Science 37, Bernadette was the Executive Director of Clinical Trials at Quest Diagnostics, where she built patient and provider outreach and data and technology solutions to support the life sciences industry. Earlier in her career, Ms Tosti held a variety of clinical development technology, patient engagement and sales positions with increasing responsibility at IQVIA, inVentiv, and Veritas Medicine. She holds a bachelor’s degree in English from Boston College.

Access Webinar Now!